A plain-language reference on the compounds people are talking about. What each one is, how it works, what the research actually shows, and where it stands with regulators. No hype, no sales.
The most evidenced compound here. Approved for type 2 diabetes and weight management, with large phase 3 trials behind it.
The only FDA-approved GHRH analog. Strong phase 3 evidence for reducing visceral fat in a defined patient population.
An investigational triple agonist showing the largest weight reductions yet seen in peptide trials. Not yet approved anywhere.
Genuine phase 2/3 human trial data across several rare diseases, with mixed results. Not yet approved for any condition.
A naturally occurring peptide studied for its role in metabolism and exercise. Human therapeutic data is very limited.
Popular in recovery circles, but the evidence is almost entirely from animal studies. Banned in sport and not approved for human use.
A coenzyme central to cellular energy. Supplements reliably raise blood levels, but functional benefits in humans remain mixed.
An interesting mechanism with cell and animal support, but independently verified human evidence is essentially absent.
The best-studied compound here for skin. Topical trials show measurable collagen and firmness gains. Widely used in cosmetics.
A four-peptide research blend. No trials exist on the combination itself, only on its individual parts.
A three-peptide research blend marketed for recovery and skin. As with KLOW, the blend itself is untested.
Each compound is graded on the strength of its human evidence and labelled with its regulatory status. A compound being popular is not the same as a compound being proven. Where the research is thin or limited to animals, the page says so plainly. Start with About Peptides if the terms are new to you.